Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones

Journal of Medicinal Chemistry
1980.0

Abstract

The synthesis and pharmacological potencies of oxytocin and lysine-vasopressin analogues are reported in which the N5-amide of their glutaminyl residues are dialkylated. These analogues have been studied as an ongoing exploration of the biological effects on the natural hormones of substituting individually one of the amino acid residues, which has a hydrophilic side chain and which are thought to be part of the hydrophilic surface of the hormones. [4-(N5,N5-Dimethylglutamine)]oxytocin (17), [4-(N5,N5-di-n-propylglutamine)]oxytocin (18), and [4-(N5,N5-dimethylglutamine)] lysine-vasopressin (19) were synthesized by clasical solution techniques. Potencies in the in vitro rat uterotonic, avian vasodepressor, rat pressor, and rat antidiuretic assays were determined and are as follows, respectively: for compound 17 3.01 +/- 0.14 units/mg, 4.55 +/- 0.03 units/mg, tachyphylaxis and tachyphylaxis; for compound 18 less than 0.1, less than 0.1, less than 0.05, and less thad 1.88 +/- 0.04 units/mg. The potencies in all cases are significantly less than those of the parent hormone. The results are discussed in terms of the proposed biologically active conformations of the hormones at the uterotonic receptor and at the antidiuretic receptor.

Knowledge Graph

Similar Paper

Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones
Journal of Medicinal Chemistry 1980.0
Synthetic metabolites of neurohypophyseal hormones. [Des-9-glycinamide]oxytocin and [des-9-glycinamide,des-8-leucine]oxytocin
Journal of Medicinal Chemistry 1976.0
Synthesis and some pharmacological properties of oxytocin and vasopressin analogs with sarcosine or N-methyl-L-alanine in position 7
Journal of Medicinal Chemistry 1983.0
Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones
Journal of Medicinal Chemistry 1976.0
Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7
European Journal of Medicinal Chemistry 2007.0
Design of potent antagonists of the vasopressor response to arginine-vasopressin
Journal of Medicinal Chemistry 1978.0
Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins
Journal of Medicinal Chemistry 1977.0
Enhanced selectivity of oxytocin antagonists containing sarcosine in position 7
Journal of Medicinal Chemistry 1994.0
Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid),4-threonine]oxytocin (hydroxy[4-thr]oxytocin), a peptide with strikingly high oxytocic potency, and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin)
Journal of Medicinal Chemistry 1976.0
Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of [cyclo-(1-L-aspartic acid, 6-L-.alpha.,.beta.-diaminopropionic acid)]oxytocin
Journal of Medicinal Chemistry 1978.0